Abstract

<div>Abstract<p>Accumulating evidence reveals a significant correlation between angiopoietin 2 (Ang2) expression and tumor invasion and metastasis in various human cancers, but the major focus of recent studies has been on the angiogenic effects of Ang2. We recently reported that Ang2-stimulated glioma cell invasion results from the up-regulation and activation of matrix metalloprotease 2 (MMP-2) in tumor cells. In this study, we identify a novel mechanism by which Ang2 stimulates MMP-2 expression leading to glioma cell invasion. We show that Ang2 interacts with α<sub>v</sub>β<sub>1</sub> integrin in Tie2-deficient human glioma cells, activating focal adhesion kinase (FAK), p130<sup>Cas</sup>, extracellular signal–regulated protein kinase (ERK) 1/2, and c-jun NH<sub>2</sub>-terminal kinase (JNK) and substantially enhancing MMP-2 expression and secretion. The Ang2/α<sub>v</sub>β<sub>1</sub> integrin signaling pathway was attenuated by functional inhibition of β<sub>1</sub> and α<sub>v</sub> integrins, FAK, p130<sup>Cas</sup>, ERK1/2, and JNK. Furthermore, expression of a negative regulator of FAK, FAK-related nonkinase, by U87MG/Ang2–expressing glioma xenografts suppressed Ang2-induced MMP-2 expression and glioma cell infiltration in the murine brain. These data establish a functional link between Ang2 interaction with α<sub>v</sub>β<sub>1</sub> integrin and glioma cell invasion through the FAK/p130<sup>Cas</sup>/ERK1/2 and JNK-mediated signaling pathway. (Cancer Res 2006; 66(2): 775-83)</p></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.